These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34301297)

  • 1. Transcriptomic profiling of high- and low-spiking regions reveals novel epileptogenic mechanisms in focal cortical dysplasia type II patients.
    Srivastava A; Kumar K; Banerjee J; Tripathi M; Dubey V; Sharma D; Yadav N; Sharma MC; Lalwani S; Doddamani R; Chandra PS; Dixit AB
    Mol Brain; 2021 Jul; 14(1):120. PubMed ID: 34301297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide DNA Methylation and RNAseq Analyses Identify Aberrant Signalling Pathways in Focal Cortical Dysplasia (FCD) Type II.
    Dixit AB; Sharma D; Tripathi M; Srivastava A; Paul D; Prakash D; Sarkar C; Kumar K; Banerjee J; Chandra PS
    Sci Rep; 2018 Dec; 8(1):17976. PubMed ID: 30568293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
    Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling in human iPS-derived neuronal progenitor lines from Focal Cortical Dysplasia patients.
    Majolo F; Marinowic DR; Machado DC; Da Costa JC
    Int J Dev Neurosci; 2018 Oct; 69():112-118. PubMed ID: 30048676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of ictal and interictal epileptiform discharges and high frequency oscillations for delineating the epileptogenic zone in patients with focal cortical dysplasia.
    Cuello-Oderiz C; von Ellenrieder N; Sankhe R; Olivier A; Hall J; Dubeau F; Gotman J
    Clin Neurophysiol; 2018 Jun; 129(6):1311-1319. PubMed ID: 29523391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gray-matter-specific MR imaging improves the detection of epileptogenic zones in focal cortical dysplasia: A new sequence called fluid and white matter suppression (FLAWS).
    Chen X; Qian T; Kober T; Zhang G; Ren Z; Yu T; Piao Y; Chen N; Li K
    Neuroimage Clin; 2018; 20():388-397. PubMed ID: 30128277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial omics reveals molecular changes in focal cortical dysplasia type II.
    Vermeulen I; Rodriguez-Alvarez N; François L; Viot D; Poosti F; Aronica E; Dedeurwaerdere S; Barton P; Cillero-Pastor B; Heeren RMA
    Neurobiol Dis; 2024 Jun; 195():106491. PubMed ID: 38575092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
    Li S; Zang Z; He J; Chen X; Yu S; Pei Y; Hou Z; An N; Yang H; Zhang C; Liu S
    Oncotarget; 2017 Jan; 8(4):6883-6895. PubMed ID: 28036289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Task-induced gamma band effect in type II focal cortical dysplasia: An exploratory study.
    Souci S; Petton M; Jung J; Bourdillon P; Bouet R; Richard-Mornas A; Streichenberger N; Catenoix H; Montavont A; Isnard J; Guenot M; Kahane P; Lachaux JP; Rheims S
    Epilepsy Behav; 2018 Aug; 85():76-84. PubMed ID: 29909256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specific DNA methylation landscape in focal cortical dysplasia ILAE type 3D.
    Wang DD; Katoch M; Jabari S; Blumcke I; Blumenthal DB; Lu DH; Coras R; Wang YJ; Shi J; Zhou WJ; Kobow K; Piao YS
    Acta Neuropathol Commun; 2023 Aug; 11(1):129. PubMed ID: 37559109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and identification of novel candidate biomarkers of focal cortical dysplasia type II via bioinformatics analysis.
    Wang JY; Li Y; Lv YY; Jiang L
    Childs Nerv Syst; 2022 May; 38(5):953-960. PubMed ID: 35112146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated expression of acid-sensing ion channel 1a in cortical lesions of patients with focal cortical dysplasia.
    Guo W; Chen X; He JJ; Wei YJ; Zang ZL; Liu SY; Yang H; Zhang CQ
    J Mol Neurosci; 2014 Jun; 53(2):176-82. PubMed ID: 24682892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net synaptic drive of fast-spiking interneurons is inverted towards inhibition in human FCD I epilepsy.
    Cho E; Kwon J; Lee G; Shin J; Lee H; Lee SH; Chung CK; Yoon J; Ho WK
    Nat Commun; 2024 Aug; 15(1):6683. PubMed ID: 39107293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can histologically normal epileptogenic zone share common electrophysiological phenotypes with focal cortical dysplasia? SEEG-based study in MRI-negative epileptic patients.
    Lagarde S; Scholly J; Popa I; Valenti-Hirsch MP; Trebuchon A; McGonigal A; Milh M; Staack AM; Lannes B; Lhermitte B; Proust F; Benmekhbi M; Scavarda D; Carron R; Figarella-Branger D; Hirsch E; Bartolomei F
    J Neurol; 2019 Aug; 266(8):1907-1918. PubMed ID: 31055634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
    Arena A; Zimmer TS; van Scheppingen J; Korotkov A; Anink JJ; Mühlebner A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Vezzani A; Baayen JC; Idema S; Iyer AM; Perluigi M; Mills JD; van Vliet EA; Aronica E
    Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based lipidomic analysis reveals altered lipid profile in brain tissues resected from patients with focal cortical dysplasia (FCD).
    Kumar K; Yadav N; Banerjee J; Tripathi M; Sharma MC; Lalwani S; Siraj F; Chandra PS; Sengupta S; Dixit AB
    Epilepsy Res; 2021 Nov; 177():106773. PubMed ID: 34564036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesion focused radiofrequency thermocoagulation of bottom-of-sulcus focal cortical dysplasia type IIb: Conceptional considerations with regard to the epileptogenic zone.
    Wellmer J
    Epilepsy Res; 2018 May; 142():143-148. PubMed ID: 29550061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal Cortical Dysplasia and Refractory Epilepsy: Role of Multimodality Imaging and Outcome of Surgery.
    Jayalakshmi S; Nanda SK; Vooturi S; Vadapalli R; Sudhakar P; Madigubba S; Panigrahi M
    AJNR Am J Neuroradiol; 2019 May; 40(5):892-898. PubMed ID: 31000525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging in identifying focal cortical dysplasia and prognostic factors in pediatric and adolescent epilepsy surgery.
    Kim YH; Kang HC; Kim DS; Kim SH; Shim KW; Kim HD; Lee JS
    Epilepsia; 2011 Apr; 52(4):722-7. PubMed ID: 21275980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.